CROSS-REFERENCE TERMINAL ... SEE ALSO
  RECORD ................. /gsk-whistleblower-suppression-unfavorable-research
  STATUS ................. ACTIVE
  CROSS-REFERENCES ....... 1 (1 OUT / 0 IN)
  NAVIGATION ............. CLICK A CARD TO WALK THE ARCHIVE

GSK Whistleblower Claims: Suppression of Unfavorable Research Findings

◂ RECORDS ROOM PULL THE FULL ANNOTATION →

REGISTER

→ PARALLEL-PATTERN Study 329: Paroxetine Clinical Trial Data Suppression and Publication Bias [file] — The broader narrative around GSK whistleblowers and misconduct aligns with the theme of pharmaceutical companies potentially suppressing unfavorable data, as seen in the Study 329 case involving paroxetine.